Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials

This publication has 19 references indexed in Scilit:

• Levetiracetam, a New Antiepileptic Agent: Lack of In Vitro and In Vivo Pharmacokinetic Interaction with Valproic Acid
  Epilepsia, 2003
• The Importance of Drug Interactions in Epilepsy Therapy
  Epilepsia, 2002
• Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers
  Epilepsy Research, 2001
• Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating Monotherapy
  Epilepsia, 2000
• Levetiracetam for partial seizures
  Neurology, 2000
• Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New Technique
  The Journal of Clinical Pharmacology, 2000
• A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy
  Seizure, 2000
• Pharmacokinetic profile of levetiracetam
  Pharmacology & Therapeutics, 2000
• Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
  Published by Elsevier ,1998
• ucb L059, a novel anti-convulsant drug: pharmacological profile in animais
  European Journal of Pharmacology, 1992